J&J Shares Fall 3.5%, Quickly Rebound From Lows But Still Down ~2.5% For Session; Traders Circulate Mesothelioma.net Article 'Johnson & Johnson Mesothelioma Trial Likely to Expose Company Documents'
Paul Quintaro